A348150 Share Price Performance
₩5,170.00
-2750.00 (-34.72%)
Price ₩5,170.00
Share Price₩5,170.00
A348150 Community Narratives
There are no narratives available yet.
Recent A348150 News & Updates
No updates
KoBioLabs, Inc Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -294.16
- Gross Margin
- 71.09%
- Net Profit Margin
- -8.07%
- Debt/Equity Ratio
- 28.6%
KoBioLabs, Inc Competitors
About A348150
- Founded
- n/a
- Employees
- 50
- CEO
- WebsiteView website
KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and neurological diseases. The company is based in Seongnam-si, South Korea.
South Korean Market Performance
- 7 Days: 3.2%
- 3 Months: 22.8%
- 1 Year: 20.7%
- Year to Date: 31.3%
In the last week, the market has stayed flat, however the Utilities sector stood out, gaining 6.3%. Meanwhile, the market is actually up 23% over the past year. Earnings are forecast to grow by 22% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading